丹红注射液治疗急性脑梗死的临床效果观察

发布时间：2018-05-01 15:21

  本文选题：丹红注射液 + 急性脑梗死　； 参考：《现代诊断与治疗》2016年19期

【摘要】：选取2014年8月~2015年12月我院收治的68例急性脑梗死患者。随机均分为对照组和观察组各34例,两组在抗血小板聚集、降脂及对症等常规治疗的基础上,对照组给予丹参注射液,观察组给予丹红注射液,比较两组临床疗效、神经功能缺损程度评分及日常生活能力等情况。观察组的有效率为91.48%,明显高于对照组的70.59%,两组比较差异有统计学意义(P0.05)。治疗后,观察组的NIHSS评分与ADL评分明显优于对照组,两组比较差异有统计学意义(P0.05)。丹红注射液治疗急性脑梗死的疗效确切,能够明显改善神经功能缺损程度,提高患者的日常生活能力。
[Abstract]:From August 2014 to December 2015, 68 patients with acute cerebral infarction were selected. They were randomly divided into two groups: control group (n = 34) and observation group (n = 34). On the basis of antiplatelet aggregation, lipid lowering and symptomatic routine treatment, the control group was given Danshen injection, the observation group was given Danhong injection, and the two groups were treated with Danhong injection. Neurological impairment score and ability of daily living. The effective rate of the observation group was 91.48, which was significantly higher than that of the control group (70.59). The difference between the two groups was statistically significant (P 0.05). After treatment, the NIHSS score and ADL score in the observation group were significantly better than those in the control group, and the difference between the two groups was statistically significant (P 0.05). Danhong injection is effective in the treatment of acute cerebral infarction. It can obviously improve the degree of nerve function defect and improve the daily life ability of the patients.
【作者单位】： 重庆市九龙坡区第二人民医院;
【分类号】：R743.33
，

本文编号：1829944